NCT03493100

Brief Summary

The aim of this study is to evaluate long-term effects of early and prolonged individualized and optimized nutritional support using ONS for four weeks, in combination with a defined physiotherapy regimen, on sarcopenia and other outcome parameters in elderly fracture patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
106

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 15, 2016

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

June 21, 2017

Completed
10 months until next milestone

First Posted

Study publicly available on registry

April 10, 2018

Completed
20 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2018

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 25, 2018

Completed
Last Updated

October 26, 2018

Status Verified

April 1, 2018

Enrollment Period

1.6 years

First QC Date

June 21, 2017

Last Update Submit

October 25, 2018

Conditions

Keywords

oral nutritional supplementationgeriatricsbone fracture

Outcome Measures

Primary Outcomes (1)

  • hand grip strength

    The primary endpoint is the change in muscle functionality of the study groups after 4 weeks by the measurement of hand grip strength using Jamar®-Dynamometer.

    Participants will be followed from day 1 to day 180. Examinations take place at discharge, after 4 weeks, after 3 months and after 6 months.

Secondary Outcomes (18)

  • Nutritional status

    Participants will be followed from day 1 to day 180. Examinations take place at discharge, after 4 weeks, after 3 months and after 6 months.

  • Mobility

    Participants will be followed from day 1 to day 180. Examinations take place at discharge, after 4 weeks, after 3 months and after 6 months.

  • Arm/leg circumference

    Participants will be followed from day 1 to day 180. Examinations take place at discharge, after 4 weeks, after 3 months and after 6 months.

  • Extracellular to body cell mass ratio (ECM/BCM - Ratio)

    Participants will be followed from day 1 to day 180. Examinations take place at discharge, after 4 weeks, after 3 months and after 6 months.

  • Skinfold thickness

    Participants will be followed from day 1 to day 180. Examinations take place at discharge, after 4 weeks, after 3 months and after 6 months.

  • +13 more secondary outcomes

Study Arms (2)

oral nutritional supplementation

EXPERIMENTAL

This group receives optimized nutritional support, by ONS for a period of four weeks.

Dietary Supplement: oral nutritional supplementation

Control

OTHER

The control group will receive treatment according to usual care.

Other: Usual care

Interventions

The intervention group will receive optimized nutritional support, by ONS. While hospitalized each patient receives 2 portions of oral supplementation per day. For remaining days supplementation is calculated individually according to a sarcopenia/energy balance schema resulting in none or maximum 2 portions per day.

oral nutritional supplementation

The control group will receive treatment according to usual care.

Control

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • age ≥ 75 years, or
  • age ≥ 65 years and Carlson-Comorbidity-Index of ≥ 5 and
  • written informed consent

You may not qualify if:

  • progressive cancer disease
  • relevant pre-existing chronic conditions (in order to avoid disease related impact on outcome parameters)
  • insufficient German speech intelligibility

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Hohenheim

Stuttgart, 70599, Germany

Location

MeSH Terms

Conditions

Fractures, Bone

Interventions

Dietary Supplements

Condition Hierarchy (Ancestors)

Wounds and Injuries

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Stephan C. Bischoff

    University of Hohenheim

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 21, 2017

First Posted

April 10, 2018

Study Start

September 15, 2016

Primary Completion

April 30, 2018

Study Completion

October 25, 2018

Last Updated

October 26, 2018

Record last verified: 2018-04

Locations